FDA Inspection
Evonik Rexim (Nanning) Pharmaceutical Co. Ltd.Evonik Rexim (Nanning) Pharmaceutical Co. Ltd. – FDA Inspection, Sep 28, 2018
Record Details
This FDA Inspection record concerns Evonik Rexim (Nanning) Pharmaceutical Co. Ltd., with an inspection on September 28, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- September 28, 2018
- Product Type
- Drugs
View Company Profile
ID · 6da192bb-f430-4ee1-a8db-9626306d8e9e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1068951
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Evonik Rexim (Nanning) Pharmaceutical Co. Ltd.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| April 11, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 13, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Evonik Rexim (Nanning) Pharmaceutical Co. Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.